Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Deep Brain Stimulation + Therapy for Stroke

NCT: NCT07849114 · NOT_YET_RECRUITING

NCT IDNCT07849114
StatusNOT_YET_RECRUITING
Start Date2027-01
Completion2030-07
SponsorPirondini, Elvira, PhD (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and potential benefits of combining deep brain stimulation (DBS) with targeted speech and swallowing rehabilitation in individuals who have experienced a stroke and have moderate to severe difficulties with speech and/or swallowing. Speech difficulties may include apraxia, which affects the ability to plan and coordinate speech movements, and dysarthria, which affects the ability to produce clear speech. Participants may also have difficulty swallowing (dysphagia). The primary objective of this feasibility study is to evaluate the safety of the SR-DBS system in individuals with post-stroke speech and swallowing difficulties. The secondary objective is to evaluate whether combining DBS with speech and swallowing rehabilitation improves motor speech and swallowing function and reduces related impairments. The study will compare outcomes following rehabilitation alone with outcomes following rehabilitation combined with DBS to determine whether the addition of DBS provides greater improvements in speech and swallowing function.

Frequently Asked Questions

What is Deep Brain Stimulation + Therapy for Stroke?

Deep Brain Stimulation + Therapy for Stroke is a clinical trial registered under NCT07849114. Current status: NOT_YET_RECRUITING.

What is the status of NCT07849114?

The current status of NCT07849114 (Deep Brain Stimulation + Therapy for Stroke) is: NOT_YET_RECRUITING.

When did Deep Brain Stimulation + Therapy for Stroke start?

Deep Brain Stimulation + Therapy for Stroke started on 2027-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑